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Abstract
Background: Several measures have been implemented at international level to ensure that there
is a greater focus on sex differences in health research. This study evaluates the effect of various
formal incentives that were introduced by a Dutch financer of health research to encourage
applicants to include sex differences in research proposals.
Methods: We sampled 213 health research proposals submitted in 2003 to the programmes
Prevention (N = 104) and Innovation (N = 109) by the Netherlands Organization for Health
Research and Development (ZonMw). These proposals were analysed and categorized with regard
to the expressed intention to take sex differences into consideration. Furthermore, those
proposals in which such intention was absent were appraised by researchers to determine whether
an intention of this kind would have been relevant.
Results: We found that 23 % of proposals submitted to Prevention (incentive: programme specific
instructions) and 10% of those submitted to Innovation (general set of guidelines) took account of
sex differences (difference 13%; 95% CI: 3.1–22.9). Conversely, 66% of the research proposals in
Prevention, and 20% in Innovation, failed to take sex differences into consideration, even though
this might well have been relevant.
Conclusion: There is still insufficient incentive for those submitting research proposals to ZonMw
to systematically incorporate sex differences when drafting such documents. The provisions in
ZonMw's policy need to be amended and better monitored. For this, we formulated some
recommendations.
Background
Health research is the basis of optimal health care deliv-
ery. Public organizations for the funding of health
research play a key role in supporting this research. In the
past, women were often under-represented among the
subjects participating in clinical health research studies
[1]. This was based on the belief that, aside from the
reproductive system, males and females had basically the
same biology. Another factor was a system of research eth-
ics which sought to protect female test subjects of child-
bearing age from harm, should they become pregnant. In
the 1980s, scientists and women's health activists, partic-
ularly in North America, began to express concerns about
this approach to research. It was feared that the under-rep-
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resentation of women in clinical research would hamper
an accurate understanding of the impact of biological sex
factors or socially constructed gender factors on health
and disease, and that this might lead to less appropriate
health care delivery for both sexes [1].
In several countries, public organizations for the funding
of health research have responded to this situation by
adapting their policies to take account of these concerns.
In 1993, the National Institutes of Health (NIH) Revitali-
zation Act was approved by the US Congress. Since then,
the NIH has required that men, women and minorities
should be adequately represented in clinical studies. It
further stipulates that research designs should allow valid
and meaningful analysis of differences between the sexes
[2].
In 1997, following the adoption of a general policy to
improve women's health, Health Canada introduced a
guideline for drug research and registration. The aim was
to encourage the inclusion of women at all stages of drug
development, and to facilitate the detection of significant
sex-related differences in drug response [3].
The revised NIH policy has been evaluated by studies car-
ried out both by the United States General Accounting
Office (GAO) and by independent researchers. These
studies suggest that, while progress has indeed been made
in the recruitment of women for NIH-funded research,
research reports often fail to include an analysis of data by
sex [4-6]. Marrocco et al. evaluated the intentions of Cana-
dian clinical investigators to recruit individuals of both
sexes and to analyse data by sex. This involved an exami-
nation of research ethics applications at a Canadian
health sciences centre over a five-year period (1995–
2000). Their study revealed that 97.6% of researchers
working on non-sex-specific conditions intended to
recruit both men and women, while only 20.2% planned
to perform analyses of data by sex [7].
In 2000, the European parliament also made a clear com-
mitment to promote gender equality in EU-funded
research. The aim was to achieve a balanced participation
of male and female scientists in projects (40% women),
while ensuring that studies focus on sex and gender
related factors [8]. Researchers participating in the 6th
Framework Programme (FP6), which runs from 2002 to
2007, were asked to describe and justify the composition
of their study populations according to sex. They were also
required to indicate how they plan to integrate a focus on
sex and gender issues, where appropriate, into the objec-
tives and methodology of their research proposals. They
were also asked to provide a gender action plan [9]. Both
these measures and the gender action plans are currently
the subject of monitoring studies, the results of which will
be made available following the completion of FP6 in
2007.
In his study of international health research policies pro-
moting sensitivity to sex or gender differences, Caron
noted that national health research funding organizations
in various European countries have also undertaken initi-
atives to promote greater sensitivity to sex differences in
health research. No assessment of these initiatives, in the
form of published studies, is yet available [10].
The Netherlands Organization for Health Research and
Development (ZonMw) is one of the above-mentioned
organizations. ZonMw is the main source of government
funding for health research in the Netherlands. It funds a
broad range of health research, both basic and applied, as
well as research into the implementation of health care
improvements. To this end, it has many different grant
programmes, each with its own research focus and set of
priorities [11]. In 1999, ZonMw adopted the general pol-
icy that its financial support is subject to the provision
that studies must give sufficient emphasis to diversity fac-
tors, such as sex, age and ethnicity [12]. The organization
implemented this new policy in two different ways. All
those putting forward and assessing grant proposals were
provided with a set of guidelines. These contained general
information about ZonMw's commitment to an adequate
focus on diversity factors in health research. Furthermore,
within several grant programmes, changes were also made
to the instructions for grant applicants (and for those
reviewing grant applications). These modifications
involved the inclusion of specific questions on diversity
issues.
The aim of the present study is to evaluate the success of
this diversity policy in encouraging applicants to take sex
differences into consideration when drafting research pro-
posals.
To this end, we reviewed various research proposals that
were submitted to two ZonMw programmes in 2003. The
programmes in question were Innovative Research (Inno-
vation) and Prevention in Health Care (Prevention).
Applicants to the first of these programmes were only
given general information about ZonMw's commitment
to ensuring that due consideration is given to diversity fac-
tors in health research. In the instructions accompanying
the application form, those applying to the second pro-
gramme were specifically asked if they were aware of any
relevant sex, age or cultural differences with respect to
their study's target population. If this was the case, they
were asked how the study would take these differences
into consideration (see table 1).International Journal for Equity in Health 2007, 6:13 http://www.equityhealthj.com/content/6/1/13
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We determined the number of proposals submitted to
each programme which expressed the intention to take sex
differences into consideration. We also identified those
proposals in which no such intention was expressed, even
though the topic of research indicated that it might have
been relevant.
Methods
The general procedure for applying for grants at ZonMw
consists of three phases. First, applicants are asked to sub-
mit a brief summary of the study for which they are seek-
ing grant support. These abridged proposals are reviewed
by the ZonMw committee responsible for the programme
in question. In the second phase, ZonMw invites a limited
number of applicants to write a detailed grant proposal. In
the third stage, following a peer review of these detailed
proposals by experts in the field, the applicants are invited
to respond to the reviewers' comments. On the basis of
this response, the proposals are awarded their final grade.
Those with the best grades are earmarked for grants
[11,13,14]. The initial abridged proposals provide a good
impression of the research questions that the applicants
intend to answer, and of the methodology that they
intend to use, prior to any interference from the peer
reviewers. For this reason, we decided to use these initial
proposals as the basis of our study.
Characteristics of the programmes
We selected proposals that had been submitted to
ZonMw's Prevention and Innovation programmes. Vari-
ous characteristics of the programmes in question are
described below.
Prevention is a four-year programme commissioned by
the Ministry of Health. It has a total budget of € 48 mil-
lion. Consisting of three sub-programmes, it provides
grants for basic, applied, and implementation studies
which focus on the primary and secondary prevention of
medical conditions. The 2003 call for proposals listed the
programme's priorities as chronic conditions, mental
health, infectious diseases, and health promotion, as well
as the methods and organization associated with health
promotion strategies [13]. The purpose of the Innovation
programme is to encourage innovative research on any
theme by highly respected research groups [14]. This may
include basic, clinical, population-based, or health sys-
tems research. The programme has an annual budget of 8
million euro [15]. See table 2 for examples of studies that
have been approved for funding by these programmes.
Data collection and analysis
We selected all 109 proposals submitted to the Innova-
tion programme in 2003. The three sub-programmes of
the Prevention programme received 313 proposals in
2003. Turboran, a randomization program, was used to
Table 1: Summary of guidelines regarding the consideration of diversity factors for grant proposals of two Programmes of ZonMw: 
Innovation and Prevention.
General instructions of ZonMw for writing grant proposals
Relevance
"ZonMw has a number of general spear-points: sex (gender differences), culture (cultural differences in prevention and care for citizens from a variety of 
backgrounds), age (extra focus on young people and the elderly) and the point-of-view of patients/consumers (cooperation with the ultimate target group). 
These factors are specifically involved in the assessment, serving as relevance criteria. The grant applications should contain an adequate explanation of the 
reasons for including the aspects in question in the study, or for omitting them, as the case may be. In projects where this is relevant, the process of quality 
assurance (..) will include a check to determine whether these factors have been adequately fleshed out in the project plan."
Quality.
Under the heading of "Quality", certain constraints are imposed on the content of the Action Plan: "Where appropriate, the Action Plan also gives details of the 
way in which the factors of gender, age, cultural background and/or other relevant characteristics that form an essential part of the objective, have been fleshed 
out....".
Programme Prevention 
In the list of instructions of the grant proposal form:
- under subheading "objective" is mentioned:
"provide a description of the target group (if there is one), categorizing 
relevant details by gender, age, cultural background and/or other relevant 
characteristics".
-under subheading"work plan" is mentioned:
"where a target group is involved, indicate how the factors of gender, age, 
cultural background and/or any other relevant characteristics that form an 
essential part of the objective will be addressed; you should also indicate the 
extent of any collaboration with the intermediate or ultimate target group (the 
point-of-view of patients/consumers)"
Programme Innovation 
There is no reference to sex or gender in the proposal form's list of 
instructions
There is no reference to sex or gender in the proposal form itself There is no reference to sex or gender in the proposal form itselfInternational Journal for Equity in Health 2007, 6:13 http://www.equityhealthj.com/content/6/1/13
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randomly select 37% (115) of the proposals submitted to
the three sub-programmes. The purpose was to obtain
comparable numbers of proposals from both of the main
programmes (Prevention and Innovation). Eleven pro-
posals submitted to the Prevention programme were dis-
carded as they were not available in digital form.
To determine how many research proposals expressed the
intention to consider sex differences, a content analysis
was conducted of all the selected proposals. To protect the
anonymity of the applicants, only one researcher was
allowed access to the full proposals and the content anal-
ysis had to be carried out at ZonMw's offices, under the
supervision of a member of staff. DGK conducted the
analysis. The aim was to search for references to an inten-
tion to study sex differences1 in the aims and objectives
sections, and in the work plan or the methodology sec-
tions. To this end the following steps were taken:
Firstly, the following data were recorded for all proposals:
full title and the type of study: basic study, applied study,
implementation study, and whether or not the study con-
sidered a non-sex-specific condition. Two of the proposals
for applied studies in the Prevention Programme dealt
with conditions that only occur in one sex (menopause,
post-partum incontinence). These proposals were not
included in the next step of content analysis, as we were
only interested in studies of conditions that can occur in
both sexes (further details of the definitions used and
practices adopted are available from the corresponding
author).
Secondly, all proposals that considered non-sex-specific
conditions were read in full, with a focus on the following
questions:
• Are sex differences considered in the aim of the study?
• Are sex differences considered in the objective of the
study?
• Does the work plan give details of how sex differences
will be analysed?
To double check the content analysis, a word scan was
performed on the proposals using the following query:
sex, gender, male, female, men, women, boy, girl.
All proposals that produced an affirmative answer to one
of the three questions above were included in the category
of proposals reflecting the intention to consider sex differ-
ences. The proposals in question were also coded accord-
ing to the degree to which the intention to consider sex
differences was fleshed out in the proposal:
• "Little intention": if one of the three above questions
was answered affirmatively.
• "Marked intention": if two or three of the above ques-
tions were answered affirmatively.
Following the selection of those proposals which con-
tained an intention to consider sex differences, two other
researchers were asked to assess the remaining proposals,
to determine in which cases it may have been relevant to
focus on sex differences. Both of these researchers have
broad expertise in biomedicine and public health.
To protect the applicants' privacy, our researchers were
only allowed to screen the titles of the studies in question,
rather than the proposals themselves. For that reason a
document was created with a list of titles of those remain-
ing proposals that did not reflect the intention to consider
sex differences.
The researchers were asked to screen these titles individu-
ally and to assign them to the following broad categories:
• Consideration of sex differences not to be expected, given
what is known about the topic of the study.
Table 2: Examples of research proposals approved by the two programmes in question (randomly chosen) [16].
Prevention+ Innovation+
-Risk prediction based on vascular risk factors; Development of an 
instrument for guiding preventive measures in the elderly.
-Rehabilitation and Sports: a study on the effect of a sports and 
physically active lifestyle stimulation programme during and after the 
regular rehabilitation treatment, on the degree of sports participation, 
daily physical activity and health status in a population of rehabilitating 
patients.
-Development and evaluation of an educational intervention targeted at 
optimizing adherence to measures aimed at preventing asthma in 
children with a familial allergic disposition.
-Cellular reprogramming in neuromuscular tissues as a response to 
genetic lesions in the cellular network for energy homeostasis – 
Adaptation and (programmed) cell death.
-Towards gene therapy for haemophilia: a research programme on the 
transfer of the genes for factor VIII and IX into hepatocytes and into the 
liver.
-Functional and molecular characterization of the role of cytokines in 
development of human lymphocytes.
-The role of the glycocalyx in myocardial perfusion and coronary 
endothelial function in health and disease
+As a result of privacy considerations, no titles of grant research proposals included in this study are shown.International Journal for Equity in Health 2007, 6:13 http://www.equityhealthj.com/content/6/1/13
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• Consideration of sex differences could have been expected,
given what is known about the topic of the study.
The researchers were not given a rigorously fixed list to
guide their decisions, because we assumed that their
knowledge of the field would be sufficient to this end. The
inter-rater agreement was measured using Cohen's kappa.
The value obtained was 0.47. Where there was disagree-
ment, the researchers sought to achieve consensus
through discussion.
Comparison of the programmes
Specific data on the total number of proposals that did or
did not express the intention to consider sex differences is
presented for each of the programmes. This data is classi-
fied according to study type (basic, applied, implementa-
tion).
The two programmes were compared on the proportion
of proposals with a positive intention to consider sex dif-
ferences. To determine whether the difference in propor-
tions was significant, the 2-sided Fisher Exact test was
used. For the difference in proportions 95% confidence
intervals were calculated. Inclusion of the value zero in
the interval indicates that the difference is not statistically
significant at the 5% level. We expected the proportion of
proposals with a positive intention to be lower in the
Innovation programme than in the Prevention pro-
gramme, because the latter programme had taken more
explicit measures to encourage this. Because the intention
to consider sex differences varied with study type and
because the distribution of protocols across study type
varied between the two programmes, proportions were
also adjusted for study type and subsequently compared,
using the Mantel-Haenszel test for stratified analysis.
Computations were conducted using Stata 9.2. software
(StataCorp, Texas, USA)
Results
Of the total of 104 proposals received by the Prevention
programme, we identified 24 proposals (23%) in which
investigators expressed the intention to consider sex dif-
ferences in their study's aims, objectives or work plan (see
table 3). For seven of these proposals, this intention was
fleshed out in the aim and/or objectives as well as in the
work plan (classified as a "Marked intention"). Of the 109
research proposals that were submitted to the Innovation
programme, 11 proposals (10%) were found to express an
intention to consider sex differences. Of these, 3 actually
gave specific details of this throughout the proposal. The
two programmes differed in the composition according to
study type. Whereas most of the studies submitted to the
Prevention programme were either applied or implemen-
tation studies (93 out of 104), most of the studies submit-
ted to the Innovation programme were basic studies (94
out of 109).
In the Prevention programme, 80 of the 104 proposals
did not express an intention to focus on sex differences
(see table 4). Two of these proposals dealt with conditions
that only occur in one sex and were classified as consider-
ation of sex differences "not to be expected". According to
the opinion of the two experts, in 69 of those 80 proposals
(66% of total) it may well have been relevant to do so. In
the Innovation programme, 98 of the 109 proposals did
not address sex differences. With respect to 22 of those 98
proposals (20% of total), the experts expressed the view
that this might well have been relevant. If we combine the
data regarding the types of study submitted to both pro-
grammes, table 4 shows that 54 of the 69 (78%) proposals
for applied studies that did not intend to address sex dif-
Table 3: Proposals in which the applicants expressed an intention to consider sex, subdivided into study type
Intention to consider sex differences Present Absent Number of proposals submitted
All Marked Little
N (%) N (%) N (%) N (%) N (%)
Programme Prevention 24 (23%) 7 (7%) 17 (16%) 80 (77%) 104 (100%)
Study type
basic 3214 7
applied 18 5 13 59 77
implementation 2021 4 1 6
classification unclear 1013 4
Programme Innovation 11 (10%) 3 (3%) 8 (7%) 98 (90%) 109 (100%)
Study type
basic 9368 5 9 4
applied 1011 0 1 1
implementation 0000 0
classification unclear 1013 4International Journal for Equity in Health 2007, 6:13 http://www.equityhealthj.com/content/6/1/13
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ferences could have been expected to do this according to
the experts. This was the case for 19 of the 89 (21%) pro-
posals for basic studies of this category and for 13 of the
14 (93%) proposals for implementation studies.
A comparison between the two grant programmes
showed that the Prevention programme received a signif-
icantly higher proportion of proposals expressing an
intention to consider sex differences than the Innovation
programme (table 5). The difference between the two pro-
grammes was 13.0 % (95% CI, 3.1–22.9) when no adjust-
ment is made for the differences with respect to the types
of study that were submitted to the two programmes. The
difference is 19.5% (95% CI, 1.4–37.6) when adjustments
are made for study type. We did not find any significant
differences between the two programmes for the different
study types.
Discussion
Towards the end of the 1990s, the Netherlands Organiza-
tion for Health Research and Development was one of a
group of international public organizations for the fund-
ing of health research that introduced the policy of
encouraging health research workers to focus on diversity
factors. The present study analysed proposals submitted
to two important ZonMw grant programmes in 2003, to
determine whether they gave any consideration to sex dif-
ferences. Those that did not do so were subjected to a fur-
ther examination by two experts to determine whether a
consideration of these differences would have been rele-
vant.
The Prevention programme involved a greater effort to
alert applicants to ZonMw's diversity policy. In contrast to
the Innovation programme, the instructions for appli-
cants contained more specific references regarding diver-
sity issues. This may account for the fact that, relative to
the Innovation programme, the Prevention programme
received a greater proportion of proposals (13%) express-
ing the intention to focus on sex differences. However, it
should also be noted that in 66% of the proposals submit-
ted to the Prevention programme that did not address sex
differences, it might have been relevant to do so according
to the experts. By contrast, this was only the case in 20%
of the proposals submitted to the Innovation programme.
This raises questions with regard to the effectiveness of the
approach taken by the Prevention programme. We found
that only 21 % of the proposals for basic studies submit-
ted to both programmes that did not intend to address sex
differences could have been expected to do this according
to the experts, while this was the case for 78% of the pro-
posals for applied studies and for 93% of the proposals for
implementation studies. This suggest that the proposals
for basic studies in our sample performed relatively well
with respect to an expected consideration of sex differ-
ences. This finding is intriguing, as the general recognition
that sex is an important variable that should be taken into
account in basic research is a relatively recent develop-
ment [17-20]. Further research is needed to determine
specific barriers and facilitating factors for the considera-
tion of sex differences in the design of applied, implemen-
tation and basic studies.
This study was subject to the following limitations. Firstly,
it was based on the initial, abridged research proposals
that were submitted to ZonMw. It could be argued that the
full proposals which ZonMw receives in the later stages of
the grant application cycle might have provided more
information concerning the approach to sex differences
adopted by the project in question. However, we believe
that the initial proposals provide an accurate impression
of the way in which the research community interprets
Table 4: Proposals in which the applicants did not express an intention to consider sex+, subdivided into study type.
Intention to consider sex differences Expected Not expected Total no intention Number of proposals submitted
N (%) N (%) N (%) N (%)
Programme Prevention 69 (66%) 11 (11%) 80 (77%) 104 (100%)
Study type
basic 40 4 7
applied 48 10 59++ 77
implementation 13 1 14 15
classification unclear 30 3 4
Programme Innovation 22 (20%) 76 (70%) 98 (90%) 109 (100%)
Study type
basic 15 70 85 94
applied 64 1 0 1 1
implementation 00 0 0
classification unclear 12 3 4
+ experts made an assessment by screening the title of a proposal
++ includes one proposal on which the experts were indecisive whether attention to sex differences could have been relevant or not.International Journal for Equity in Health 2007, 6:13 http://www.equityhealthj.com/content/6/1/13
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ZonMw's diversity policy. Secondly, although our initial
aim was to determine whether a given research proposal
expressed an intention to consider sex and/or gender dif-
ferences, this was found to be impossible in practice. The
reason for this is that while these concepts are well
defined in the literature [21-23], investigators still use
them interchangeably when writing research proposals.
Accordingly, we were unable to determine whether the
proposed studies addressed sex differences, gender differ-
ences, or both. Thirdly, when assessing the proposals that
did not focus on sex differences, to determine in which
cases it may have been relevant to do so, our researchers
were only allowed to screen the titles of the studies in
question. This was done in order to protect the applicants'
privacy. A full reading of the proposals may have led to
somewhat different judgements. Furthermore, the two
researchers did not screen the titles of the earlier selected
group of proposals that reflected an intention to focus on
sex differences. This might have been a useful check of
their method for screening the interest of sex differences
for the topic of the study, only on the basis of the available
titles. Despite these limitations, it is our contention that
the list of proposals selected by our researchers gives a
good impression of those studies in which a consideration
of sex differences may have been relevant.
Our study suggests that the way in which this ZonMw pol-
icy has been implemented, particularly in the Innovation
programme, does not give applicants sufficient incentive
to routinely consider sex differences when drafting their
research proposals. ZonMw's diversity policy is very broad
based. It is intended to encourage the inclusion of numer-
ous diversity factors in a wide range of studies (basic,
applied and intervention). By adopting an open approach
of this kind, ZonMw has opted to grant applicants consid-
erable freedom in selecting what they consider to be rele-
vant to their requirements, and in discarding what is not.
Indeed, a previous analysis of health proposals submitted
to ZonMw concluded that some researchers tended to pre-
fer a consideration of ethnic variations above sex or gen-
der differences [24].
At international level, there is considerable variation in
the policies that public organizations for the funding of
health research employ in an attempt to heighten the
focus on sex differences. For instance, unlike the ZonMw
policy, the NIH policy is supported by legislation. Fund-
ing is conditional upon compliance, and the policies of
the NIH, Health Canada and the EU are more tightly
focussed on promoting a consideration of sex differences
in particular [3,8,25-27]. These policies have also been
more regularly monitored than the ZonMw policy. The
monitoring in question is carried out either by the organ-
izations themselves or by independent researchers. These
studies showed that the inclusion of both sexes in a study
does not automatically lead to the analysis and reporting
of data by sex [4-7]. This, together with other results, has
prompted these organizations to take further actions to
enhance guidance. Indeed, for many researchers in health
research, the idea that a consideration of sex or gender dif-
ferences could be relevant to their research is still some-
thing of a novelty. As the NIH inclusion policy has shown,
any attempt to encourage a greater focus on sex differences
in research involves complex procedures and requires
considerable endurance [4-6,28].
This study suggests that ZonMw's current diversity policy
may be too broad, and that investigators need better guid-
ance if they are to take sex differences into account in their
Table 5: Comparison of proposals with expressed intention to consider sex differences between the programmes Prevention and 
Innovation; overall, per study type and adjusted for study type.
Proposals expressing intention to consider sex differences Difference between programmes
Prevention (N = 104) Innovation (N = 109) Absolute 95% CI+
%N%N %
Overall (F) 23% 24/104 10% 11/109 13.0 3.1–22.9*
Study type/difference corrected (F)
basic 43% 3/7 10% 9/94 33.3 -3.9–70.4
applied 23% 18/77 9% 1/11 14.3 -5.2–33.7
implementation 12% 2/16 0 0 - -
classification unclear 25% 1/4 25% 1/4 0++ -60.0–60.0
Overall, adjusted for study type (M) 22/88 11/109 19.5 1.4–37.6*
+ CI: Confidence interval
(F) 2-sided Fisher Exact test
(M) Mantel-Haenszel test. Study type 'implementation' is excluded from the stratified analysis because the type is not represented in the program 
Innovation.
* significant (p ≤ 0.05)International Journal for Equity in Health 2007, 6:13 http://www.equityhealthj.com/content/6/1/13
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research proposals. Therefore we formulated some recom-
mendations.
Firstly, in order to help applicants understand what is
expected from them, they must be supplied with a clear set
of instructions. One example of clearly written instruc-
tions is the amended NIH Policy and Guidelines on the
Inclusion of Women and Minorities as Subjects in Clinical
Research [29]. Another is the Vademecum for Scientific
Officers and Project Officers produced by the EU's Direc-
torate General of Research [9].
Secondly, it should be made clear to applicants that the
reviewers of their research proposals will be carrying out
specific checks to determine whether sex differences have
been appropriately addressed.
Thirdly, initiatives should be launched to provide appro-
priate training for the staff of organizations that fund
health research, as well as for present and future appli-
cants and reviewers. The training in question should
address the relevance of focussing on sex differences in
health research, giving examples of how this should be
done in different types of studies (basic, applied, imple-
mentation). Here too, the materials produced by the NIH
Office of Women's Health and the EU are useful examples
[9,30].
Fourthly, as with any policy, progress should be moni-
tored regularly. Furthermore, clear indicators are needed
in order to measure progress.
Conclusion
In conclusion, 35 of the 213 proposals submitted to two
ZonMw programmes in 2003 expressed the intention to
address sex differences. ZonMw's diversity policy may
have had a role in this. The Prevention programme
attracted more proposals paying attention to sex differ-
ences than the Innovation program. This may be due to
the fact that the first programme provided more explicit
instructions on how to address this topic to applicants.
However, for 91 of the 178 proposals that indicated no
intention to consider sex differences, it was evident from
the subject matter in the proposals that such considera-
tions may have been appropriate. Many of those propos-
als involve applied and implementation studies. The
provisions of ZonMw's present policy need to be
amended and there must be better monitoring, to ensure
that sex differences are systematically addressed in the
development of research proposals.
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Appendix- Footnotes
1The terms sex and gender are often used interchangeably
in the literature and by ZonMw, and in this article we use
the term sex to refer to male/female differences, biological
sex differences as well as socially constructed gender dif-
ferences.
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